The University of Alabama at Birmingham (UAB) will receive $148,500 through August 31, 2025 to conduct research targeting Schwann cell-mediated cancer progression and metastasis under a Project Grant from the Defense Health Agency.
This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve military and public health through innovative medical solutions. The funding will allow UAB researchers to investigate how Schwann cells, a type of glial cell, influence cancer growth and spread in order to develop new therapeutic approaches for oncology patients.
Generated 1/23/24, 11:52 AM